Worst performer was AMYT:Amryt Pharma, falling 11% which accounts for over £500 of the losses on its own. CWR:Ceres Power Holdings dropped 9% which was expensive and RED:RedT Energy dropped 7% after a truly dreadful trading statement confirming that they haven't sold anything ever.
Although OPTI:Optibiotix only fell 3%, the 2p drop cost me £600 now these make up 33% of the portfolio. The encouraging thing with this situation is that they could spectacularly turn around my current deficit if they get back to their 80p range.
It wasn't all doom and gloom, with JLP:Jubilee Platinum posting a really upbeat interview with the CEO boosting confidence that the next trading statement could be a good one, although still no news about Tjate. This led to a 7% rise in share price.
Share of the Week is back to IQE:IQE following a brief stint as worst performer last week. This week the shares climbed back by 12% to recover half last week's losses.
Bad news - just a few short weeks in the black, but last time it took a similar dip it was back up again within a few weeks. Only 3 weeks before the year 2 review though, so it would be really nice to be in the black for that.
Here's the combined ISA and share accounts
| Weekly Change | |||
| Portfolio cost | £46,246.68 | +£631.79 | |
| Portfolio sell value (bid price - commission) | £43,214.99 | (-6.6%) | -£1,307.34 |
| Potential profits | £4,785.20 | -£1,141.47 | |
| Yr 2 Dividends | £500.59 | +£0 | |
| Yr 2 Profit from sales | £2,872.24 | +£471.18 | |
| Yr 2 Average monthly cash profit | £294.63 | (7.6%) | +£36.40 |
| Total Dividends | £1,168.52 | +£0 | |
| Total Profit from sales | £6.712.50 | +£471.18 | |
| Average monthly cash profit | £333.77 | (8.7%) | +£17.08 |
| (Sold stocks profit + Dividends - Fees / Months) |
Portfolio cost up by £631 after re-investing the proceeds of selling SXX:Sirius Minerals and TLOU:Tlou Energy and some old dividends into more OPTI:Optibiotix. Sell value is down by £1,307 when you factor that the cost went up £631. Most of this was reduced paper profits, with the £471 from the sales and the rest a combination of AMYT:Amryt Pharma, CWR:Ceres Power and GVC:GVC Holdings all dropping. Losses deepened a small amount, but it was nearly all reduced profits this week.
Average monthly performance improved thanks to the sales, but only enough to go from 8.3% to 8.7%. The policy of selling fewer shares in year 2 has clearly had an impact, with year 2 performance only 7.6%, but at least there's some hope of the portfolios getting into the black unlike last year when I kept spending any profits.
A horrible drop, but I've had them just as big before so lets hope for a repeat of the rise that started in week 91.
The SIPP looks like this after week 85
| Weekly Change | |||
| Portfolio cost | £17,853.50 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,066.00 | (6.8%) | -£157.48 |
| Potential profits | £3,180.01 | +£61.53 | |
| Yr 2 Dividends | £294.96 | +£0 | |
| Yr 2 Profit from sales | £1,596.81 | +£0 | |
| Yr 2 Average monthly cash profit | £240.79 | (16.2%) | -£7.53 |
| Total Dividends | £708.15 | +£0 | |
| Total Profit from sales | £3,946.67 | +£0 | |
| Average monthly cash profit | £231.76 | (15.6%) | -£2.76 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits are actually up a little thanks to IQE:IQE, but this was reduced by declining paper profits in CAML:Central Asia Metals and LGEN:Legal & General which lost most of last week's rise. The 2p fall in OPTI:Optibiotix is responsible for turning the increased profits into a £157 loss. Performance is still well above 10% target and will be for some time.
Still in the black, but the gap has been narrowing for a few weeks now.
The pointless trading account looks like this just one week before the first year aniversary
| Weekly Change | |||
| Portfolio cost | £486.05 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £335.55 | (-31%) | -£13.90 |
| Potential profits | £0 | +£0 | |
| Dividends | £1.15 | +£1.15 | |
| Profit from sales | -£22.85 | +£0 | |
| Average monthly cash profit | -£1.84 | (-4.6%) | +£0.14 |
| (Sold stocks profit + Dividends - Fees / Months) |
The usual yo-yo by REDS:RedstoneConnect continues, with a 3% swing in each direction every single week. Much excitement though - the fragments from the share consolidation have been returned, so I counted it as a £1.15 dividend. This improved the average monthly loss by 14p a month - stunning!
I look at the graph and reflect what could have been, if I wasn't really crap at picking trading shares.
No planned announcements that I'm aware of next week, so the big hope is that OPTI:Optibiotix release some form of news to help it bounce off the 60p zone. Both JLP:Jubilee Platinum and KIBO:Kibo Mining were looking upbeat last week, so there's hope that momentum will continue, and CWR:Ceres Power are getting more publicity at the moment so that could be a boost to the share price, with a 35% increase being forecast by analysts. Fingers crossed...
No comments:
Post a Comment